Corcell

CorCell was a healthcare company specializing in the collection, processing, and cryogenic storage of umbilical cord blood and cord tissue stem cells. Established as one of the first private cord blood banks in the United States, it provided families with the opportunity to preserve stem cells for potential use in treating over 80 life-threatening diseases, including leukemias and metabolic disorders. The company operated as a subsidiary of Cord Blood America before its customer accounts and brand assets were acquired by Cord Blood Registry (CBR) in 2015. Today, its legacy operations are part of the CooperSurgical family of companies. CorCell's services were primarily marketed to expectant parents as a form of biological insurance for future medical needs. The company maintained high standards of quality, holding accreditations from organizations such as the AABB.